Ocular adnexal marginal zone lymphoma (OAMZL)

Show full item record

Files in this item

PDF 11-2018-OcularAdnexalMZLID1778.pdf 689.4Kb

Pour citer ce document :
URI: http://hdl.handle.net/2042/70531  |   DOI : https://doi.org/10.4267/2042/70531
Title: Ocular adnexal marginal zone lymphoma (OAMZL)
Author: Bongiovanni, Lucia; Ponzoni, Maurilio
Abstract: Ocular adnexal marginal B-cell lymphoma (OAMZL) is the most common type of primary lymphoma of this anatomical site. OAMZL is a rare entity, accounting for 1-2% of all non-Hodgkin lymphomas. A pathogenetic link with chronic infection by Chlamydia psittaci has been demonstrated in some geographical areas. Because of its rarity and the paucity of focused studies the clinical management of OAMZL is still controversial and uniform guidelines are not presently available.
Subject: Marginal zone lymphoma; MALT; Ocular adnexa; Chlamydia psittaci; Leukaemia Section; Adult; Aged; Antineoplastic Agents, Immunological/therapeutic use; Autoimmune Diseases/*complications; Female; Humans; Kaplan-Meier Estimate; Lymphoma, B-Cell/complications/*drug therapy; Lymphoma, Large B-Cell, Diffuse/complications/*drug therapy; Male; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment (Health Care)/methods/statistics & numerical data; Prognosis; Proportional Hazards Models; Risk Factors; Rituximab/*therapeutic use; Autoimmunity; Biopsy; Disease Management; Eye/*pathology
Publisher: ARMGHM - Atlas Génétique des Cancers
Date: 2019

This item appears in the following Collection(s)

Show full item record

Advanced Search